Benoit Beuselinck

Prof Dr

KU Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof Dr. Benoit Beuselinck is a faculty member at KU Leuven in Belgium. His research focuses on oncology, particularly in relation to renal cell carcinoma and advanced breast cancer. He has contributed significantly to understanding treatment responses and outcomes in cancer patients, as evidenced by his recent publications on immune checkpoint inhibitors and novel therapeutics.

Articles (7)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Maxime Meylan

Dana-Farber Cancer Institute

UNITED STATES

View details

Els Wauters

Universitaire Ziekenhuizen Leuven

BELGIUM

View details

catherine sautes-fridman

Emeritus Professor

Université Paris Descartes

FRANCE

View details

Jan A. Staessen

Prof. dr. (Emeritus Professor of Medicine)

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Benoit Beuselinck

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives

Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis

Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors

Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort

Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma

Collaborators (4)

Maxime Meylan

Els Wauters

catherine sautes-fridman

Jan A. Staessen

Make your next move.